Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:05 AM ET 8-K
Investor Presentation Energy Fuels Inc UUUU

Energy Fuels Investor Presentation

Energy Fuels Inc. has filed an updated investor presentation following its Q3 2026 financial results and the completion of its acquisition of Australian Strategic Materials Ltd. (ASM). The presentation provides updated strategic highlights and operational data for investors following these major corporate milestones.

6:04 AM ET 10-Q
Financial Results MSD Investment Corp. MSD

MSD Investment Q3 2026 Results: Net Income $94.2M, Up 27.6% YoY

MSD Investment Corp. reported total assets of $7.48 billion as of September 30, 2026, with a net asset value per share of $23.54. The company increased its total debt to $3.82 billion, primarily driven by higher utilization of its revolving credit facility and the issuance of unsecured notes.

Key figure
Net income $94.2M · +27.6% YoY
6:04 AM ET 10-Q
Financial Results Figure Certificate Co

Figure Certificate Q3 2026 Results: Turns Profitable, Net Income $571K

Figure Technology Solutions, Inc. has committed to providing financial support to Figure Certificate Company to ensure it can satisfy all obligations and debt service requirements through at least December 31, 2027. Additionally, the Parent company has agreed to waive repayment of all existing and future loans, advances, and operating expenses incurred by the Company during this period.

Key figure
Net income $571K
6:04 AM ET 10-Q
Financial Results Macquarie Energy Transition Infrastructure Fund, L.P.

Macquarie Energy Transition Infrastructure Fund Q2 2026 Results: Turns Profitable, Net Income $2.07M

Macquarie Energy Transition Infrastructure Fund, L.P. reported total assets of $209.1 million as of September 30, 2026, a significant increase from $132.7 million in March 2026, primarily driven by investments in affiliated funds. The fund operates as an emerging growth company and reported 1,052,536 Class E units and 449,610 Class I units outstanding as of the period end.

Key figure
Net income $2.07M
6:01 AM ET 8-K
Business Update Capital One Financial Corp COF

Capital One Financial Business Update

Capital One Financial Corporation disclosed its monthly credit performance metrics for October 2026, reporting a 4.02% net charge-off rate for its domestic credit card business. The company also reported a 30+ day performing delinquency rate of 3.87% for credit cards and 4.68% for its auto loan portfolio.

Term
month ended October 31, 2026
9:59 PM ET Form 4
Insider Buying Nexgel, Inc. NXGL

Nexgel Interim CEO Brian Joseph Kieser Buys $733K of Stock

Brian Joseph Kieser, Interim CEO, bought 133,216 shares of Nexgel, Inc. at $5.50 a share, worth $733K in total on Nov 10, 2026. Shares held after the trade: 133,216.

Value
$733K
Shares
133,216
Price
$5.50
Role
Interim CEO
Trade date
Nov 10, 2026
9:58 PM ET Form 4
Insider Buying Nexgel, Inc. NXGL

Nexgel Insider steven mark glassman Buys $25K of Stock

steven mark glassman bought 4,546 shares of Nexgel, Inc. at $5.50 a share, worth $25K in total on Nov 10, 2026. Shares held after the trade: 12,379 (+58.0%).

Value
$25K
Shares
4,546
Price
$5.50
Holding change
+58.0%
Trade date
Nov 10, 2026
9:44 PM ET Form 4
Insider Buying Neuronetics, Inc. STIM

Neuronetics Insider Jorey Chernett Buys $79.6K of Stock

Jorey Chernett bought 40,000 shares of Neuronetics, Inc. at $1.99 a share, worth $79.6K in total on Nov 9, 2026. Shares held after the trade: 10,306,225 (+0.4%).

Value
$79.6K
Shares
40,000
Price
$1.99
Holding change
+0.4%
Trade date
Nov 9, 2026
9:44 PM ET Form 4
Insider Selling Neuronetics, Inc. STIM

Neuronetics Insider Jorey Chernett Sells $4.48M of Stock

Jorey Chernett sold 3,335,411 shares of Neuronetics, Inc. at $1.15 to $2.39 a share (average $1.34) in 5 transactions, worth $4.48M in total between Nov 6, 2026 and Nov 13, 2026. Shares held after the trade: 7,325,577 (-23.0%).

Value
$4.48M
Shares
3,335,411
Average price
$1.34
Holding change
-23.0%
Trade date
Nov 6, 2026 to Nov 13, 2026
9:43 PM ET Form 4
Insider Selling Exagen Inc. XGN

Exagen Insider Jorey Chernett Sells $746K of Stock

Jorey Chernett sold 167,504 shares of Exagen Inc. at $4.08 to $4.65 a share (average $4.45) in 2 transactions, worth $746K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 2,529,436 (-2.2%).

Value
$746K
Shares
167,504
Average price
$4.45
Holding change
-2.2%
Trade date
Nov 12, 2026 to Nov 13, 2026
9:32 PM ET Form 4
Insider Buying Vivani Medical, Inc. VANI

Vivani Medical Chief Business Officer Donald Dwyer Buys $15.5K of Stock

Donald Dwyer, Chief Business Officer, bought 15,000 shares of Vivani Medical, Inc. at $1.03 a share, worth $15.5K in total on Nov 12, 2026. Shares held after the trade: 75,000 (+25.0%).

Value
$15.5K
Shares
15,000
Price
$1.03
Role
Chief Business Officer
Holding change
+25.0%
Trade date
Nov 12, 2026
9:23 PM ET Form 4
Insider Selling Fair Isaac Corp FICO

Fair Isaac President and CEO William J. Lansing Sells $184K of Stock

William J. Lansing, President and CEO, sold 250 shares of Fair Isaac Corp at $735.00 a share, worth $184K in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).

Value
$184K
Shares
250
Price
$735.00
Role
President and CEO
Holding change
-100.0%
Trade date
Nov 12, 2026
9:22 PM ET Form 4
Insider Selling Fair Isaac Corp FICO

Fair Isaac President and CEO William J. Lansing Sells $14.8M of Stock

William J. Lansing, President and CEO, sold 20,465 shares of Fair Isaac Corp at $715.51 to $732.00 a share (average $723.31) in 28 transactions, worth $14.8M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 250 (-28.2%).

Value
$14.8M
Shares
20,465
Average price
$723.31
Role
President and CEO
Holding change
-28.2%
Trade date
Nov 11, 2026 to Nov 12, 2026
9:21 PM ET Form 4
Insider Buying Starwood Property Trust, Inc. STWD

Starwood Property Trust Director Jonathan Lee Pollack Buys $2.01M of Stock

Jonathan Lee Pollack, Director, bought 169,800 shares of Starwood Property Trust, Inc. at $11.84 to $11.88 a share (average $11.86) in 2 transactions, worth $2.01M in total on Nov 11, 2026. Shares held after the trade: 84,800.

Value
$2.01M
Shares
169,800
Average price
$11.86
Role
Director
Trade date
Nov 11, 2026
9:20 PM ET Form 4
Insider Buying Starwood Property Trust, Inc. STWD

Starwood Property Trust CEO, Chairman of the Board Barry S. Sternlicht Buys $14.7M of Stock

Barry S. Sternlicht, CEO, Chairman of the Board, bought 1,245,000 shares of Starwood Property Trust, Inc. at $11.59 to $11.91 a share (average $11.81) in 2 transactions, worth $14.7M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 1,498,421 (+38.3%).

Value
$14.7M
Shares
1,245,000
Average price
$11.81
Role
CEO, Chairman of the Board
Holding change
+38.3%
Trade date
Nov 11, 2026 to Nov 12, 2026
9:05 PM ET Form 4
Insider Selling Natera, Inc. NTRA

Natera Director Jonathan Sheena Sells $479K of Stock

Jonathan Sheena, Director, sold 1,500 shares of Natera, Inc. at $315.26 to $324.76 a share (average $319.30) in 14 transactions, worth $479K in total on Nov 11, 2026. Shares held after the trade: 7,500 (-0.5%).

Value
$479K
Shares
1,500
Average price
$319.30
Role
Director
Holding change
-0.5%
Trade date
Nov 11, 2026
9:05 PM ET Form 4
Insider Selling LifeStance Health Group, Inc. LFST

LifeStance Health Group Insider Ryan Pardo Sells $40.9M of Stock

Ryan Pardo sold 2,804,505 shares of LifeStance Health Group, Inc. at $14.58 a share, worth $40.9M in total on Nov 10, 2026. Shares held after the trade: 334,935 (-86.9%).

Value
$40.9M
Shares
2,804,505
Average price
$14.58
Holding change
-86.9%
Trade date
Nov 10, 2026
9:02 PM ET Form 4
Insider Selling Alamar Biosciences, Inc. ALMR

Alamar Biosciences 10% Owner Qiming Corporate GP VI Ltd. Sells $2.94M of Stock

Qiming Corporate GP VI Ltd., 10% Owner, sold 100,061 shares of Alamar Biosciences, Inc. at $29.34 to $30.63 a share (average $29.38) in 7 transactions, worth $2.94M in total on Nov 11, 2026. Shares held after the trade: 1,632,188 (-0.0%).

Value
$2.94M
Shares
100,061
Average price
$29.38
Role
10% Owner
Holding change
-0.0%
Trade date
Nov 11, 2026
8:44 PM ET Form 4
Insider Selling Live Nation Entertainment, Inc. LYV

Live Nation Entertainment EVP, M&A and Strategic Finance John Hopmans Sells $2.01M of Stock

John Hopmans, EVP, M&A and Strategic Finance, sold 11,133 shares of Live Nation Entertainment, Inc. at $180.50 a share, worth $2.01M in total on Nov 13, 2026. Shares held after the trade: 163,299 (-6.4%).

Value
$2.01M
Shares
11,133
Price
$180.50
Role
EVP, M&A and Strategic Finance
Holding change
-6.4%
Trade date
Nov 13, 2026
8:44 PM ET Form 4
Insider Selling Live Nation Entertainment, Inc. LYV

Live Nation Entertainment President & CFO Joe Berchtold Sells $16.7M of Stock

Joe Berchtold, President & CFO, sold 93,537 shares of Live Nation Entertainment, Inc. at $178.21 to $180.03 a share (average $178.84) in 3 transactions, worth $16.7M in total on Nov 13, 2026. Shares held after the trade: 901,617 (-1.1%).

Value
$16.7M
Shares
93,537
Average price
$178.84
Role
President & CFO
Holding change
-1.1%
Trade date
Nov 13, 2026
8:20 PM ET Form 4
Insider Selling MediaAlpha, Inc. MAX

MediaAlpha CTO Kuanling Amy Yeh Sells $176K of Stock

Kuanling Amy Yeh, CTO, sold 12,000 shares of MediaAlpha, Inc. at $14.69 a share, worth $176K in total on Nov 13, 2026. Shares held after the trade: 481,091 (-2.4%).

Value
$176K
Shares
12,000
Price
$14.69
Role
CTO
Holding change
-2.4%
Trade date
Nov 13, 2026
8:13 PM ET Form 4
Insider Buying indie Semiconductor, Inc. INDI

indie Semiconductor Director David J. Aldrich Buys $299K of Stock

David J. Aldrich, Director, bought 130,000 shares of indie Semiconductor, Inc. at $2.30 a share, worth $299K in total on Nov 11, 2026. Shares held after the trade: 393,392 (+49.4%).

Value
$299K
Shares
130,000
Price
$2.30
Role
Director
Holding change
+49.4%
Trade date
Nov 11, 2026
8:04 PM ET Form 4
Insider Selling Oruka Therapeutics, Inc. ORKA

Oruka Therapeutics SVP, Finance Arjun Agarwal Sells $1.05M of Stock

Arjun Agarwal, SVP, Finance, sold 10,000 shares of Oruka Therapeutics, Inc. at $101.98 to $107.00 a share (average $104.97) in 6 transactions, worth $1.05M in total on Nov 12, 2026. Shares held after the trade: 14,219 (-0.7%).

Value
$1.05M
Shares
10,000
Average price
$104.97
Role
SVP, Finance
Holding change
-0.7%
Trade date
Nov 12, 2026
8:00 PM ET Form 4
Insider Selling CrowdStrike Holdings, Inc. CRWD

CrowdStrike Holdings President and CEO George Kurtz Sells $6.26M of Stock

George Kurtz, President and CEO, sold 27,453 shares of CrowdStrike Holdings, Inc. at $218.98 to $237.34 a share (average $228.05) in 29 transactions, worth $6.26M in total between Nov 10, 2026 and Nov 12, 2026. Shares held after the trade: 7,225,647 (-0.0%).

Value
$6.26M
Shares
27,453
Average price
$228.05
Role
President and CEO
Holding change
-0.0%
Trade date
Nov 10, 2026 to Nov 12, 2026
8:00 PM ET Form 4
Insider Selling CrowdStrike Holdings, Inc. CRWD

CrowdStrike Holdings President and CEO George Kurtz Sells $582K of Stock

George Kurtz, President and CEO, sold 2,538 shares of CrowdStrike Holdings, Inc. at $229.30 to $230.06 a share (average $229.50) in 2 transactions, worth $582K in total on Nov 12, 2026. Shares held after the trade: 7,223,109 (-0.0%).

Value
$582K
Shares
2,538
Average price
$229.50
Role
President and CEO
Holding change
-0.0%
Trade date
Nov 12, 2026
8:00 PM ET Form 4
Insider Selling Palantir Technologies Inc. PLTR

Palantir Technologies Insider Shyam Sankar Sells $64.9M of Stock

Shyam Sankar sold 384,680 shares of Palantir Technologies Inc. at $164.81 to $175.07 a share (average $168.80) in 7 transactions, worth $64.9M in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 857,616 (-9.0%).

Value
$64.9M
Shares
384,680
Average price
$168.80
Holding change
-9.0%
Trade date
Nov 10, 2026 to Nov 11, 2026
8:00 PM ET Form 4
Insider Selling Oruka Therapeutics, Inc. ORKA

Oruka Therapeutics Insider Kristine M. Ball Sells $1.89M of Stock

Kristine M. Ball sold 18,000 shares of Oruka Therapeutics, Inc. at $102.10 to $106.98 a share (average $104.93) in 6 transactions, worth $1.89M in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).

Value
$1.89M
Shares
18,000
Average price
$104.93
Holding change
-100.0%
Trade date
Nov 12, 2026
8:00 PM ET Form 4
Insider Selling Tenet Healthcare Corp THC

Tenet Healthcare Director Roy Blunt Sells $293K of Stock

Roy Blunt, Director, sold 1,000 shares of Tenet Healthcare Corp at $293.00 a share, worth $293K in total on Nov 11, 2026. Shares held after the trade: 3,589 (-21.8%).

Value
$293K
Shares
1,000
Price
$293.00
Role
Director
Holding change
-21.8%
Trade date
Nov 11, 2026
7:59 PM ET Form 4
Insider Selling Adaptive Biotechnologies Corp ADPT

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $1.05M of Stock

Julie Rubinstein, President and COO, sold 35,228 shares of Adaptive Biotechnologies Corp at $28.93 to $31.22 a share (average $29.73) in 4 transactions, worth $1.05M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 377,802 (-2.9%).

Value
$1.05M
Shares
35,228
Average price
$29.73
Role
President and COO
Holding change
-2.9%
Trade date
Nov 11, 2026 to Nov 13, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.